Drugs / Meningococcal(Groups A, C, Y, and W-135) Conjugate Vaccine
Meningococcal(Groups A, C, Y, and W-135) Conjugate Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04714229 Comparator | Sep → Nov 2020 | meningococcal infection | EuBiologics Co.,Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal(Groups A, C, Y, and W-135) Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04714229 ↗ |
| Modality | Vaccine | “Meningococcal(Groups A, C, Y, and W-135) Conjugate Vaccine” NCT04714229 ↗ |
| Route | Intramuscular | “0.5mL single intramuscular dose on Day 0” NCT04714229 ↗ |